Tarsus Pharmaceuticals TARS Earnings Call Transcripts

NASDAQ TARS
$73.83 +2.99 (+4.22%)
At close: Nov 10, 2026 · 4:00 PM EST
4 earnings calls on file for Tarsus Pharmaceuticals, from Q4 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Tarsus Pharmaceuticals Q3 2026 Earnings Call

Nov 3, 2026 6,942 words · 30 min read
  • David NakasoneHead of Investor Relations
  • Bobak AzamianChief Executive Officer and Chairman
  • Neera ClaseChief Commercial Officer
  • Jeffrey S. FarrowChief Financial Officer and Chief Strategy Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Tarsus Pharmaceuticals Earnings Call Transcripts

Calls4
LatestNov 3, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 4 Tarsus Pharmaceuticals transcripts Register to get access to Tarsus Pharmaceuticals’s earnings call transcripts.